BACKGROUND The optimal dose or type of physical activity to control glycosylated
hemoglobin (HbA1c) in people with diabetes remains unknown. Current guidelines do not …

Type 2 diabetes mellitus is often associated with cirrhosis as comorbidities, acute illness,
medications, and other conditions profoundly alter glucose metabolism. Both conditions are …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Background Insulin icodec is an investigational once-weekly basal insulin analogue for
diabetes management. Methods We conducted a 78-week randomized, open-label, treat-to …

Background Once-daily oral semaglutide is an effective type 2 diabetes treatment. We aimed
to investigate a new formulation of oral semaglutide at higher investigational doses versus …

Objective: Previous studies revealed that hemoglobin A1c (HbA1c) increased overall in the
United States in the past decade. In addition, health inequities in type 1 diabetes (T1D) …

Background Despite the availability of effective therapies for patients with chronic kidney
disease, type 2 diabetes, and hypertension (the kidney-dysfunction triad), the results of large …

Fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are both used to diagnose
diabetes, but these measurements can identify different people as having diabetes. We used …

OBJECTIVE To evaluate change in mean clinic HbA1c from 2014 to 2021 with diabetes
technology use in adults with type 1 diabetes. RESEARCH DESIGN AND METHODS In this …

Background: The glycemia risk index (GRI) is a novel composite continuous glucose
monitoring (CGM) metric that gives greater weight to hypoglycemia than to hyperglycemia …